Dave Liebowitz

Senior Vice-President

Speciality: Early-Stage Clinical Development
Company: INOVIO
Designation: MD, PhD

Personal Information

Dr. Dave Liebowitz has over 27 years of industry experience in clinical and preclinical development in Oncology, Infectious Diseases (Virology), Vascular Biology, Inflammation and Metabolic Disorders with protein, small molecule, cellular therapeutic, and vaccine modalities. He was previously Senior Vice President, Clinical Development - Infectious Diseases at INOVIO. Prior to returning, Dr. Liebowitz was Senior Vice President, Clinical Development and Medical Affairs at Xencor, leading several immune-oncology programs. Prior to that, Dr. Liebowitz held numerous senior positions, including Chief Medical Officer at DNAtrix, an oncolytic virotherapy company in San Diego, CA; Chief Medical Officer at Vaxart, Inc. and Chief Scientific and Medical Officer for Vivaldi Biosciences, an influenza vaccine and therapeutics biotechnology company.

During his time at Vaxart, Inc., he led the successful application and negotiation process for acquiring a BARDA contract and served as the Principal Investigator of the award, leading its completion. In addition, he was an early recipient of a grant from the Bill and Melinda Gates Foundation.

Dr. Liebowitz began his academic career as an Assistant Professor of Medicine and Virology at the University of Chicago and was the Director of the Bone Marrow Transplantation Program. Dave has B.S. and M.S. degrees in Biology from Emory University, an M.D. with Honors, and a Ph.D. in Molecular Genetics and Cell Biology (Virology), both from the University of Chicago.

Scientia Meetings

Connecting Minds for Scientific Progress!

Join us in revolutionizing conferences! Scientia Meetings is launching events across the country, offering a unique platform for scientists and researchers to share knowledge, explore innovative ideas, and foster collaborations. Buy Ticket